Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Treatment

Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

Stone Clearance

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Stone Clearance — 6; 6; 3; 4 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Boston Scientific Corporation
Primary completion
Jan 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Stone Clearance
6; 6; 3; 4; 1; 0
PRIMARY
Post-procedure Catheterization
9; 9; 1; 0; 0; 1
PRIMARY
Procedure Time
46.3; 36.1
PRIMARY
Usage of Alternative Stone Extracting Devices
0; 1; 10; 9
PRIMARY
Hospital Stay
10; 8; 0; 2
SECONDARY
Number of Participants With Intraoperative Complications
0; 0
SECONDARY
Visibility During Procedure
0; 0; 0; 0; 0; 1
SECONDARY
Number of Participants With Occurrence of Retropulsion
8; 10; 2; 0; 0; 0
SECONDARY
Ability to Reach Stone Fragments
6; 9; 4; 1; 0; 0
SECONDARY
Damage to Scope or Fiber
0; 0; 10; 10; 0; 0
SECONDARY
Fiber Transmission
8; 9; 2; 1; 0; 0

Summary

Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

Eligibility Criteria

Inclusion Criteria

  • Subject will be older than 18 years of age
  • Subject was diagnosed with renal calculi meeting the following criteria:
  • Largest stone measures no more than 2cm on a single diameter and is no less than 0.8cm as defined by X-ray or CT.
  • Accumulative stone burden (addition of all stone diameters) is no more than 2.5cm.
  • Subject is a candidate for FURS procedure
  • Subject is willing and has signed the Informed Consent Form

Exclusion Criteria

  • Subject has undergone a previous treatment for stones in the same kidney
  • Subject requires another, concomitant procedure, other than FURS, to be performed during this treatment session.
  • Female subject is pregnant
  • Concomitant anticoagulant medication that cannot be suspended during surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02683993). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search